AIT should be considered for patients with evidence of specific IgE sensitization towards one or few clinically relevant allergen(s). | |
The decision to start AIT depends on various factors including: | |
• Children’s (and caregivers) preference and acceptability | |
• Adherence to treatment | |
• Severity of symptoms and pharmacotherapy requirements | |
• Efficacy of avoidance measures (e.g. house dust mites, pollens) | |
• Asthma and co-existent rhinitis | |
Potential indications: | |
• Possible prevention of new sensitizations in mono-sensitized patients | |
• IgE-associated food allergy | |
• Extrinsic atopic dermatitis |